elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Pricing
Log in
Sign up
Home
/
Subjects
/
Receptor tyrosine kinase
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Receptor tyrosine kinase
RIS
0.001
(Research Intensity Score)
Papers
188
Top papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 · 322 citations
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
2023 · 234 citations
Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy
2024 · 52 citations
Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
2016 · 3369 citations
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
2020 · 176 citations
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
2020 · 198 citations
Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial
2024 · 17 citations
Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration
2024 · 19 citations
Retinal calcium waves coordinate uniform tissue patterning of the Drosophila eye
2025 · 9 citations
Newest papers
Single-cell transcriptomic analysis reveals that the circRNA circGCLM promotes tumorigenesis and confers cisplatin resistance in NSCLC through the miR-505-3p/ERBB4 axis
2026 · 2 citations
PHGDH inhibition overcomes dabrafenib resistance through metabolic rewiring in BRAF V600E anaplastic thyroid carcinoma
2026
Pathway alteration burden derived from whole‐exome sequencing is associated with survival in primary central nervous system lymphoma
2026
Report from the National Pediatric Cancer Foundation - infantile glioma and other non-embryonal central nervous system tumors: evolving molecular advances and current treatment landscape
2026
MOVING TARGETS
2026
Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI–treated NSCLC: a cross-database real-world study
2026
Editorial: Astrocytes and immunity: unveiling their role in pain and neurodegenerative disease progression
2026
Editorial: Advancing excellence in thoracic oncology: breakthroughs and impactful discoveries
2026
Sitravatinib combined with osimertinib overcomes acquired osimertinib resistance in NSCLC by targeting AXL and the PI3K/AKT/GSK3β signaling pathway
2026
Browse all papers →
Receptor tyrosine kinase's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Receptor tyrosine kinase's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link